Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jun Won | - |
dc.contributor.author | Kim, Min-Sik | - |
dc.contributor.author | Voon, Dominic C. | - |
dc.contributor.author | Kim, Su-Jin | - |
dc.contributor.author | Bae, Jingi | - |
dc.contributor.author | Mun, Dong-Gi | - |
dc.contributor.author | Ko, Seung-Ik | - |
dc.contributor.author | Kim, Hark K. | - |
dc.contributor.author | Lee, Sang-Won | - |
dc.contributor.author | Kim, Dae-Yong | - |
dc.date.accessioned | 2021-09-02T09:08:15Z | - |
dc.date.available | 2021-09-02T09:08:15Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-07 | - |
dc.identifier.issn | 0899-1987 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/74413 | - |
dc.description.abstract | The molecular mechanisms underlying the pathogenesis of diffuse-type gastric cancer (DGC) have not been adequately explored due to a scarcity of appropriate animal models. A recently developed tool well suited for this line of investigation is the Pdx-1-Cre;Cdh1(F/+);Trp53(F/F);Smad4(F/F) (pC(he)PS) mouse model that spontaneously develops metastatic DGC showing nearly complete E-cadherin loss. Here, we performed a proteogenomic analysis to uncover the molecular changes induced by the concurrent targeting of E-cadherin, p53, and Smad4 loss. The gene expression profiles of mouse DGCs and in vivo gastric phenotypes from various combinations of gene knockout demonstrated that these mutations collaborate to activate cancer-associated pathways to generate aggressive DGC. Of note, WNT-mediated epithelial-to-mesenchymal transition (EMT) and extracellular matrix (ECM)-cytokine receptor interactions were prominently featured. In particular, the WNT target gene osteopontin (OPN) that functions as an ECM cytokine is highly upregulated. In validation experiments, OPN contributed to DGC stemness by promoting cancer stem cell (CSC) survival and chemoresistance. It was further found that Bcl-xL acts as a targetable downstream effector of OPN in DGC CSC survival. In addition, Zeb2 and thymosin-4 (T4) were identified as prime candidates as suppressors of E-cadherin expression from the remaining Cdh1 allele during DGC development. Specifically, T4 suppressed E-cadherin expression and anoikis while promoting cancer cell growth and migration. Collectively, these proteogenomic analyses broaden and deepen our understanding of the contribution of key driver mutations in the stepwise carcinogenesis of DGC through novel effectors, namely OPN and T4. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | THYMOSIN BETA-4 | - |
dc.subject | CANCER | - |
dc.subject | OSTEOPONTIN | - |
dc.subject | EXPRESSION | - |
dc.subject | ANOIKIS | - |
dc.subject | CELLS | - |
dc.subject | ADENOCARCINOMA | - |
dc.subject | INHIBITION | - |
dc.subject | CARCINOMA | - |
dc.title | Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Su-Jin | - |
dc.contributor.affiliatedAuthor | Lee, Sang-Won | - |
dc.identifier.doi | 10.1002/mc.22803 | - |
dc.identifier.scopusid | 2-s2.0-85044247573 | - |
dc.identifier.wosid | 000434229700013 | - |
dc.identifier.bibliographicCitation | MOLECULAR CARCINOGENESIS, v.57, no.7, pp.947 - 954 | - |
dc.relation.isPartOf | MOLECULAR CARCINOGENESIS | - |
dc.citation.title | MOLECULAR CARCINOGENESIS | - |
dc.citation.volume | 57 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 947 | - |
dc.citation.endPage | 954 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | THYMOSIN BETA-4 | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | OSTEOPONTIN | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | ANOIKIS | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | ADENOCARCINOMA | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordAuthor | LC-MS | - |
dc.subject.keywordAuthor | MS | - |
dc.subject.keywordAuthor | osteopontin | - |
dc.subject.keywordAuthor | thymosin 4 | - |
dc.subject.keywordAuthor | WNT signaling | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.